Table of Contents Global Neuroendocrine Tumors (NETs) Treatment Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Neuroendocrine Tumors (NETs) Treatment Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Neuroendocrine Tumors (NETs) Treatment Segment by Type 1.2.1 Somatostatin Analogs (SSAs) 1.2.2 Targeted Therapy 1.2.3 Other 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Clinics 1.3.3 Other 1.4 Overview of Global Neuroendocrine Tumors (NETs) Treatment Market 1.4.1 Global Neuroendocrine Tumors (NETs) Treatment Revenue (2015-2025) 1.4.2 Global Neuroendocrine Tumors (NETs) Treatment Production and Capacity (2015-2025) 1.4.3 North America Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2015-2025) 1.4.4 Europe Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2015-2025) 1.4.5 Japan Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2014-2025) 1.4.6 China Neuroendocrine Tumors (NETs) Treatment Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Neuroendocrine Tumors (NETs) Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Neuroendocrine Tumors (NETs) Treatment Industry 1.6.2 Neuroendocrine Tumors (NETs) Treatment Business Impact Assessment - Covid-19 1.6.3 Market Trends and Neuroendocrine Tumors (NETs) Treatment Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Neuroendocrine Tumors (NETs) Treatment Market Competition by Manufacturer 2.1 Global Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Neuroendocrine Tumors (NETs) Treatment Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Neuroendocrine Tumors (NETs) Treatment Manufacturer Market Share 2.5 Top 10 Neuroendocrine Tumors (NETs) Treatment Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Neuroendocrine Tumors (NETs) Treatment Market 2.7 Key Manufacturers Neuroendocrine Tumors (NETs) Treatment Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Neuroendocrine Tumors (NETs) Treatment Industry Key Manufacturers 3.1 Advanced Accelerator Applications 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Advanced Accelerator Applications News 3.2 AVEO Oncology 3.2.1 Company Details 3.2.2 Product Information 3.2.3 AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 AVEO Oncology News 3.3 Boehringer Ingelheim International 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Boehringer Ingelheim International News 3.4 Hutchison MediPharma Limited 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Hutchison MediPharma Limited News 3.5 IpsenPharma 3.5.1 Company Details 3.5.2 Product Information 3.5.3 IpsenPharma Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 IpsenPharma News 3.6 Novartis AG 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Novartis AG Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Novartis AG News 3.7 Pfizer, Inc 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Pfizer, Inc News 3.8 Progenics Pharmaceuticals 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Progenics Pharmaceuticals News 4 Global Neuroendocrine Tumors (NETs) Treatment Market Size Categorized by Regions (2015-2020) 4.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Region 4.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Region (2015-2019) 4.3 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Neuroendocrine Tumors (NETs) Treatment Market Size Detail 4.4.1 North America Neuroendocrine Tumors (NETs) Treatment Sales Growth Rate (2015-2020) 4.4.2 North America Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Neuroendocrine Tumors (NETs) Treatment Market Size Detail 4.5.1 Europe Neuroendocrine Tumors (NETs) Treatment Sales Growth Rate (2015-2020) 4.5.2 Europe Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Neuroendocrine Tumors (NETs) Treatment Market Size Detail 4.6.1 Japan Neuroendocrine Tumors (NETs) Treatment Sales Growth Rate (2015-2020) 4.6.2 Japan Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Neuroendocrine Tumors (NETs) Treatment Market Size Detail 4.7.1 China Neuroendocrine Tumors (NETs) Treatment Sales Growth Rate (2015-2020) 4.7.2 China Neuroendocrine Tumors (NETs) Treatment Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Neuroendocrine Tumors (NETs) Treatment Market Segment by Type 5.1 Global Neuroendocrine Tumors (NETs) Treatment Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Neuroendocrine Tumors (NETs) Treatment Sales and Market Share by Type (2015-2020) 5.1.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Market Share by Type (2015-2020) 5.2 Somatostatin Analogs (SSAs) Sales Growth Rate and Price 5.2.1 Global Somatostatin Analogs (SSAs) Sales Growth Rate (2015-2020) 5.2.2 Global Somatostatin Analogs (SSAs) Price (2015-2020) 5.3 Targeted Therapy Sales Growth Rate and Price 5.3.1 Global Targeted Therapy Sales Growth Rate (2015-2020) 5.3.2 Global Targeted Therapy Price (2015-2020) 5.4 Other Sales Growth Rate and Price 5.4.1 Global Other Sales Growth Rate (2015-2020) 5.4.2 Global Other Price (2015-2020) 6 Global Neuroendocrine Tumors (NETs) Treatment Market Segment by Application 6.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Clinics Sales Growth Rate (2015-2020) 6.4 Other Sales Growth Rate (2015-2020) 7 Neuroendocrine Tumors (NETs) Treatment Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Neuroendocrine Tumors (NETs) Treatment Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Neuroendocrine Tumors (NETs) Treatment Market Forecast 8.1 Global Neuroendocrine Tumors (NETs) Treatment Sales, Revenue Forecast 8.1.1 Global Neuroendocrine Tumors (NETs) Treatment Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Neuroendocrine Tumors (NETs) Treatment Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Neuroendocrine Tumors (NETs) Treatment Price and Trend Forecast (2020-2025) 8.2 Global Neuroendocrine Tumors (NETs) Treatment Sales Forecast by Region (2020-2025) 8.2.1 North America Neuroendocrine Tumors (NETs) Treatment Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Neuroendocrine Tumors (NETs) Treatment Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Neuroendocrine Tumors (NETs) Treatment Production, Revenue Forecast (2020-2025) 8.2.4 China Neuroendocrine Tumors (NETs) Treatment Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Neuroendocrine Tumors (NETs) Treatment Picture Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Type Figure Global Sales Market Share of Neuroendocrine Tumors (NETs) Treatment by Product Type in 2019 Table Breakdown of Neuroendocrine Tumors (NETs) Treatment by Company Type (Tier 1, Tier 2 and Tier 3) Figure Neuroendocrine Tumors (NETs) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Somatostatin Analogs (SSAs) Picture Figure Targeted Therapy Picture Figure Other Picture Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Application Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Clinics Picture Figure Other Picture Table Neuroendocrine Tumors (NETs) Treatment Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) (2015-2025) Figure Global Neuroendocrine Tumors (NETs) Treatment Production (K Units) (2015-2025) Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate (2014-2025) Figure China Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Manufacturer (2018-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Manufacturer in 2019 Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Manufacturer (2018-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Manufacturer in 2019 Table Global Neuroendocrine Tumors (NETs) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Neuroendocrine Tumors (NETs) Treatment Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Neuroendocrine Tumors (NETs) Treatment Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Neuroendocrine Tumors (NETs) Treatment Market Table Key Manufacturers Neuroendocrine Tumors (NETs) Treatment Product Type Table Mergers & Acquisitions Planning Table Advanced Accelerator Applications Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Advanced Accelerator Applications Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Advanced Accelerator Applications Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Advanced Accelerator Applications Main Business Table Advanced Accelerator Applications Recent Development Table AVEO Oncology Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of AVEO Oncology Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure AVEO Oncology Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table AVEO Oncology Main Business Table AVEO Oncology Recent Development Table Boehringer Ingelheim International Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Boehringer Ingelheim International Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Boehringer Ingelheim International Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Boehringer Ingelheim International Main Business Table Boehringer Ingelheim International Recent Development Table Hutchison MediPharma Limited Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Hutchison MediPharma Limited Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Hutchison MediPharma Limited Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Hutchison MediPharma Limited Main Business Table Hutchison MediPharma Limited Recent Development Table IpsenPharma Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of IpsenPharma Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure IpsenPharma Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table IpsenPharma Main Business Table IpsenPharma Recent Development Table Novartis AG Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Novartis AG Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis AG Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Novartis AG Main Business Table Novartis AG Recent Development Table Pfizer, Inc Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Pfizer, Inc Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Pfizer, Inc Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Pfizer, Inc Main Business Table Pfizer, Inc Recent Development Table Progenics Pharmaceuticals Company Profile Figure Neuroendocrine Tumors (NETs) Treatment Product Picture and Specifications of Progenics Pharmaceuticals Table Neuroendocrine Tumors (NETs) Treatment Production, Price, Revenue and Gross Margin of 2018-2020 Figure Progenics Pharmaceuticals Neuroendocrine Tumors (NETs) Treatment Market Share (2018-2020) Table Progenics Pharmaceuticals Main Business Table Progenics Pharmaceuticals Recent Development Table Global Neuroendocrine Tumors (NETs) Treatment Sales (K Units) by Region (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Region (2015-2019) Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Region (2015-2019) Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Region in 2018 Table Global Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) by Region (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Region (2015-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Region (2015-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Region in 2019 Table Global Neuroendocrine Tumors (NETs) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate (2015-2020) Figure Europe Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate (2015-2020) Table Europe Neuroendocrine Tumors (NETs) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate (2015-2020) Table Japan Neuroendocrine Tumors (NETs) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate (2015-2020) Table China Neuroendocrine Tumors (NETs) Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Sales by Type (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Type (2015-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Type in 2019 Table Global Neuroendocrine Tumors (NETs) Treatment Revenue by Type (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Type (2015-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue Market Share by Type in 2019 Figure Global Somatostatin Analogs (SSAs) Sales Growth Rate (2015-2025) Figure Global Somatostatin Analogs (SSAs) Price (2015-2020) Figure Global Targeted Therapy Sales Growth Rate (2015-2025) Figure Global Targeted Therapy Price (2015-2020) Figure Global Other Sales Growth Rate (2015-2025) Figure Global Other Price (2015-2020) Table Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Application (2015-2020) Figure Global Neuroendocrine Tumors (NETs) Treatment Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Neuroendocrine Tumors (NETs) Treatment Table Key Players of Downstream Markets Figure Sales Channel Figure Global Neuroendocrine Tumors (NETs) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Neuroendocrine Tumors (NETs) Treatment Price and Trend Forecast (2020-2025) Table Global Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Forecast by Region (2020-2025) Figure Global Neuroendocrine Tumors (NETs) Treatment Production Market Share Forecast by Region (2020-2025) Figure North America Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Neuroendocrine Tumors (NETs) Treatment Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Neuroendocrine Tumors (NETs) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Neuroendocrine Tumors (NETs) Treatment Production (K Units) Growth Rate Forecast (2020-2025) Figure China Neuroendocrine Tumors (NETs) Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Advanced Accelerator Applications AVEO Oncology Boehringer Ingelheim International Hutchison MediPharma Limited IpsenPharma Novartis AG